Effects of metformin use in pregnant patients with polycystic ovary syndrome

Kashif Khan, Pratap Kumar

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Use of metformin throughout pregnancy in women with polycystic ovary syndrome (PCOS) has shown to reduce the rates of early pregnancy loss, preterm labor, and prevention of fetal growth restriction. Metformin has been shown to have encouraging effects on several metabolic aspects of polycystic ovarian syndrome, such as insulin sensitivity, plasma glucose concentration and lipid profile and since women with PCOS are more likely than healthy women to suffer from pregnancy-related problems like early pregnancy loss, gestational diabetes mellitus and hypertensive states in pregnancy, the use of metformin therapy in these patients throughout pregnancy may have beneficial effects on early pregnancy loss and development of gestational diabetes.

Original languageEnglish
Pages (from-to)166-169
Number of pages4
JournalJournal of Human Reproductive Sciences
Volume5
Issue number2
DOIs
Publication statusPublished - 01-05-2012

Fingerprint

Polycystic Ovary Syndrome
Metformin
Pregnancy
Gestational Diabetes
Premature Obstetric Labor
Pregnancy Rate
Fetal Development
Insulin Resistance
Lipids
Glucose

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine

Cite this

@article{961b52b586f44fe1892f9a0d4bbcae79,
title = "Effects of metformin use in pregnant patients with polycystic ovary syndrome",
abstract = "Use of metformin throughout pregnancy in women with polycystic ovary syndrome (PCOS) has shown to reduce the rates of early pregnancy loss, preterm labor, and prevention of fetal growth restriction. Metformin has been shown to have encouraging effects on several metabolic aspects of polycystic ovarian syndrome, such as insulin sensitivity, plasma glucose concentration and lipid profile and since women with PCOS are more likely than healthy women to suffer from pregnancy-related problems like early pregnancy loss, gestational diabetes mellitus and hypertensive states in pregnancy, the use of metformin therapy in these patients throughout pregnancy may have beneficial effects on early pregnancy loss and development of gestational diabetes.",
author = "Kashif Khan and Pratap Kumar",
year = "2012",
month = "5",
day = "1",
doi = "10.4103/0974-1208.101012",
language = "English",
volume = "5",
pages = "166--169",
journal = "Journal of Human Reproductive Sciences",
issn = "0974-1208",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "2",

}

Effects of metformin use in pregnant patients with polycystic ovary syndrome. / Khan, Kashif; Kumar, Pratap.

In: Journal of Human Reproductive Sciences, Vol. 5, No. 2, 01.05.2012, p. 166-169.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Effects of metformin use in pregnant patients with polycystic ovary syndrome

AU - Khan, Kashif

AU - Kumar, Pratap

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Use of metformin throughout pregnancy in women with polycystic ovary syndrome (PCOS) has shown to reduce the rates of early pregnancy loss, preterm labor, and prevention of fetal growth restriction. Metformin has been shown to have encouraging effects on several metabolic aspects of polycystic ovarian syndrome, such as insulin sensitivity, plasma glucose concentration and lipid profile and since women with PCOS are more likely than healthy women to suffer from pregnancy-related problems like early pregnancy loss, gestational diabetes mellitus and hypertensive states in pregnancy, the use of metformin therapy in these patients throughout pregnancy may have beneficial effects on early pregnancy loss and development of gestational diabetes.

AB - Use of metformin throughout pregnancy in women with polycystic ovary syndrome (PCOS) has shown to reduce the rates of early pregnancy loss, preterm labor, and prevention of fetal growth restriction. Metformin has been shown to have encouraging effects on several metabolic aspects of polycystic ovarian syndrome, such as insulin sensitivity, plasma glucose concentration and lipid profile and since women with PCOS are more likely than healthy women to suffer from pregnancy-related problems like early pregnancy loss, gestational diabetes mellitus and hypertensive states in pregnancy, the use of metformin therapy in these patients throughout pregnancy may have beneficial effects on early pregnancy loss and development of gestational diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84866657870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866657870&partnerID=8YFLogxK

U2 - 10.4103/0974-1208.101012

DO - 10.4103/0974-1208.101012

M3 - Review article

AN - SCOPUS:84866657870

VL - 5

SP - 166

EP - 169

JO - Journal of Human Reproductive Sciences

JF - Journal of Human Reproductive Sciences

SN - 0974-1208

IS - 2

ER -